Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 2, 1996, Pages 776-783

  Daaka, Yehia ^a,b   Friedman, Herman ^a   Klein, Thomas W ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR; DRUG RECEPTOR; MESSENGER RNA; MITOGENIC AGENT;

ANIMAL; ARTICLE; BINDING SITE; CELL LINE; GENETICS; HUMAN; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; T LYMPHOCYTE;

ANIMALS; BASE SEQUENCE; BINDING SITES; CANNABINOIDS; CELL LINE; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MITOGENS; MOLECULAR SEQUENCE DATA; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0030087688     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. ABOOD, M. E., SAUSS, C., FAN, F., TILTON, C. L. AND MARTIN, B. R.: Development of behavioral tolerance to delta 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain. Pharmacol. Biochem. Behav. 46: 575-579, 1993.
2. BLALOCK, J. E.: Production of peptide hormones and neurotransmitters by the immune system. Chem. Immunol. 52: 1-24, 1992.
3. BOUABOULA, M., RINLADI, M., CAEAYON, P., CARILLON, C., DELPACH, B., SHIRE, D., LE FUR, G. AND CASELLAS, P.: Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 42: 173-180, 1993.
4. BROWN, K. D., ZURAWSKI, S. M., MOSMANN, T. R AND ZURAWSKI, G.: A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. J. Immunol. 142: 679-687, 1989.
5. BURSTEIN, S , HUNTER, S. A. AND OZMAN, K.: Prostaglandins and cannabis The effect of cannabinoid structure on the synthesis of prostaglandins by human lung fibroblasts. Mol. Pharmacol. 23:121-126, 1983.
6. CARR, D. J. J.: Neuroendocrine peptide receptors on cells nf the immune system. Chem. Immunol. 52: 84-105, 1992.
7. DAAKA, Y., KLEIN, T. W. AND FRIEDMAN, H.: Expression of cannabinoid receptor mRNA in murine and human leukocytes. In The Brain Immune Axis and Substance Abuse, ed. by B. Sharp, T. Eisenstein, J. Madden and H. Friedman, Plenum Publishing, New York, pp. 91-96, 1995.
8. DEVANE, W. A , DYSARZ, F. A. III, JOHNSON, M. R., MELVIN, L. S. AND HOWLETT, A. C : Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34: 605-613, 1988.
9. DOVE PETTIT, D. A., SHOWALTER, V M., ABOOD, M. E. AND CABRAL, G. A.: Expression of a cannabinoid receptor in baculovirus-infected insect cells. Biochem. Pharmacol. 48: 1231-1243, 1994.
10. 9-Tetrahydroeannabinol inhibition of tumor necrosis factor-α: Suppression of posttranslational events. J. Pharmacol. Exp. Ther. 267: 1558-1565, 1993.
11. GERARD, C. M , MOLLEREAU, C., VASSART, G. AND PARMENTIER, M.: Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279: 129-134, 1991.
12. 9-tetrahydrocannabinol. Biochem. Pharmacol. 27: 329-333, 1978.
13. HERKENHAM, M., LYNN, A. B., LITTLE, M. D., JOHNSON, M. R., MELVIN, L. S., DECOSTA, B. R. AND RICE, K C.: Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U.S.A. 87: 1932-1936, 1990.
14. INNIS, M. A., GELFAND, D. H., SNINSKY, J. J AND WHITE, T. J.: PCR Protocols: A Guide to Methods and Applications, Academic Press, New York, 1990.
15. KAMINSKI, N. E., ABOOD, M. E., KESSLER, F. K., MARTIN, B. R. AND SCHATZ, A R. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol. Pharmacol. 42: 736-742, 1992.
16. KAMINSKI, N. E., KOH, W. S., YANG, K. H., LEE, M. AND KESSLER, F. K.: Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem. Pharmacol. 48: 1899-1908, 1994
17. KLEIN, T. W AND FRIEDMAN, H.: Modulation of murine immune cell function by marijuana components. In Drugs of Abuse and Immune Function: ed by R R. Watson, pp. 87-111, CRC Press, Ft. Lauderdale, 1990.
18. 9-Tetrahydrocannabmol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila. J Pharmacol. Exp. Ther. 267: 635-640, 1993.
19. LIU, J. H., WEI, S., USSERY, D., EPLING-BURNETTE, P. K., LEONARD, W J. AND DJEU, J Y.: Expression of interleukin-2 receptor γ chain on human neutrophils. Blood 84; 3870-3875, 1994.
20. LYNN, A. B. AND HERKENHAM, M : Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: Implications for receptor-mediated immune modulation by cannabinoids. J. Pharmacol. Exp. Ther. 268: 1612-1623, 1994.
21. MAILLEUX, P., PARMENTIER, M AND VANDERHAEGHEN, J.-J.: Distribution of cannabinoid receptor messenger RNA in the human brain: An in situ hybridization histochemistry with oligonucleotides. Neurosci. Lett. 143: 200-204. 1992.
22. MATSUDA, L. A., LOLAIT, S. J., BROWNSTEIN, M. J., YOUNG, A. C. AND BONNER, T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (Lond.) 346: 561-564, 1990.
23. MUNRO, S., THOMAS, K. L. AND ABU-SHAAE, M.: Molecular characterization of a peripheral receptor for cannabinoids. Nature (Lond.) 365: 61-65, 1993.
24. OVIEDO, A., GLOWA, J. AND HERKENHAM, M.: Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: A quantitative autoradio-graphic study. Brain Res. 616: 293-302, 1993.
25. PULIDO, R. AND SANCHEZ-MADEID, F.: Glycosylation of CD45: Carbohydrate processing through Golgi apparatus is required for cell surface expression and protein stability. Eur. J. Immunol. 22: 463-468, 1992.
26. SHIRE, D., CARILLON, C., KAGHAD, M., CALANDRA, B., RINALDI-CARMONA, M., LEFUR, G., CAPUT, D. AND FERRARA, P.: An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem. 270: 3726-3731, 1995.
27. SINCLAIR, P. R., BEMENT, W. J., HAUGEN, S. A., SINCLAIR, J. F. AND GUZELIAN, P. S.: Induction of cytochrome P-450 and 5-aminolevulinate synthase activities in cultured rat hepatocytes. Cancer Res. 50: 5219-5224, 1990.
28. SMITH, P. B., COMPTON, D. R., WELCH, S. P., RAZDAN, R. K., MECHOULAM, R. AND MARTIN, B. R.: The pharmacological activity of anandamide, a putative endogenous eannabinoid, in mice. J. Pharmacol. Exp. Ther 270: 219-227, 1994.
29. SPECTER, S., LANCZ, G. AND FRIEDMAN, H.: Marijuana and immunosuppression in man. In Drugs of Abuse and Immune Function, ed. by R. R. Watson, pp. 73-85, CRC Press, Ft. Lauderdale, 1990.
30. 9-Tetrahydrocannabinol suppresses concanavalin A induced increase in cytoplasmic free calcium in mouse thymocytes. Life Sci. 51: 151-156, 1992.
31. + T cell clones and peripheral blood T cells. J. Immunol. 149: 2378-2384, 1992.
32. ZHENG, Z.-M., SPECTER, S. AND FRIEDMAN, H.: Inhibition by delta-9-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages. Int. J. Immunopharmacol. 14: 1445-1452, 1992.
33. ZHU, W., IGAHASHI, T., QI, Z.-T., NEWTON, C., WIDEN, R., FRIEDMAN, H. AND KLEIN, T. W.: Delta-9-Tetrahydrocannabinol (THC) decreases the number of high and intermediate affinity IL-2 receptors of the IL-2 dependent cell line NKB61A2. Int. J. Immunopharmacol. 15: 401-408, 1993.
34. 9-Tetrahydrocannabinol enhances the secretion of interleukin 1 from endotoxin-stimulated macrophages. J. Pharmacol. Exp. Ther 270: 1334-1339, 1994.